This paper is only available as a PDF. To read, Please Download here.
Objective. Hospital management of acute ischemic stroke varies greatly within and between different
countries. This study assesses the current practices and opinions of doctors in China
routinely involved in the treatment of stroke, and compares them with those of British
doctors. Methods. Questionnaires about the usual management of acute ischemic stroke were sent to
247 Chinese hospitals (mostly urban) collaborating in an acute stroke trial, seeking
responses from five doctors (one consultant, two registrars, and two house officers)
in each. After one mailing, 1,095 doctors (89%) responded. Results. Sixty-nine percent of the hospitals had computed tomography scanners, and 88% of
the doctors in those hospitals reported that they would routincly scan acute stroke
patients (78% usually within 24 hours of admission and 22% only later). Sixty-two
percent of doctors reported average hospital stays of 2 to 4 weeks, whereas 36% reported
longer average stays. Treatments reported to be used routinely within the first 48
hours of acute ischemic stroke included glycerol or mannitol (69% of doctors), Chinese
herb products (66%), calcium antagonists (54%), and aspirin (53%); for each of these
treatments, over 70% of all doctors believed it produced definite benefit. Reported
routine use of dextran (44%), snake venom (32%), “photo-therapy” (22%), and steroids
(19%) was also moderately common, and about half of all doctors believed each was
beneficial. In contrast, routine use of thrombolytic agents (4%) or anticoagulants
(1%) was uncommon. Only one third of the doctors reported active treatment of hypertension
immediately after admission. Conclusions. Comparison with a similar survey in Britain showed reported use of most treatments
for acute ischemic stroke was more extensive in China, but that within both countries
there was wide variation. The substantial variations in clinical practice both within
and between China, the United Kingdom and other countries reflect, at least in part,
the substantial uncertainty about the effectiveness of many of the possible treatments
for acute ischemic stroke. Large-scale randomized evidence is needed to confirm or
refute the efficacy of these and newer treatments for acute stroke
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- World Health Statistics Annual. World Health Organization, Geneva, Switzerland19931994
- Cerebrovascular disease in the People's Republic of China: epidemiologic and clinical features.Neurology. 1985; 35: 1708-1713
- Incidence and diagnostic features of stroke in Beijing MONICA population.Chin Med J. 1987; 7: 382-386
- Secondary prevention of vascular disease by prolonged antiplatelet treatment.BMJ. 1988; 296: 320-331
- Collaborative overview of randomised trials of antiplatelet treatment. Part I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients.BMJ. 1994; 308: 81-106
- Blood pressure, stroke, and coronary heart disease. Part II, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.Lancet. 1990; 335: 827-839
- Medical treatment of acute ischaemic stroke.Lancet. 1992; 339: 537-539
- Treating acute ischaemic stroke: still no effective drug treatment available.BMJ. 1995; 311: 139-140
- Current medical literature: The management of patients with acute ischaemic stroke.Geriatrics. 1994; 7: 99-110
- Diagnosis and treatment of ischaemic stroke.JAMA. 1991; 266: 2413-2418
- Consensus conference. Treatment of stroke. BMJ. 297. 1988: 126-128
- Acute stroke treatment in UK hospitals: the stroke association survey of consultant opinion.J R Coll Physicians Lond. 1995; 29: 479-484
- Hospital services for patients with acute stroke in the United Kingdom: the stroke association survey of consultant opinion.Age Ageing. 1995; 24: 525-532
- Multinational comparison of diagnostic procedures and management of acute stroke: the WHO MONICA Study.Cerebrovasc Dis. 1996; 6: 66-74
- Chinese Acute Stroke Trial (CAST): rationale, design and progress.Cerebrovasc Dis. 1996; 6 ([abstract, suppl 2]): 23
- Hypertension in acute ischaemic stroke, Not to treat.Arch Neurol. 1985; 42: 999-1000
- Hypertension in acute ischaemic stroke.Treat. Arch Neurol. 1985; 42: 1000-1002
- Blood pressure after stroke.JAMA. 1981; 246: 2177-2180
- Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography.Arch Neurol. 1993; 50: 855-862
- Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke.Cerebrovasc Dis. 1994; 4: 204-210
- Pathophysiology and management of hypetension in acute ischaemic stroke.Hypertension. 1994; 23: 131-136
- Blood pressure, stroke, and coronary heart disease. Part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.Lancet. 1990; 335: 765-774
- Blood pressure is an important predictor of future stroke in individuals with cerebrovascular disease.BMJ. 1996; 313: 147
- Post-stroke antihypertensive treatment study: Preliminary results.Chin Med J. 1995; 108 (Engl): 710-717
- The epidemiological association between blood pressure and stroke: implications for primary and secondary prevention.Hyperten Res. 1994; 17 (suppl 1): S23-S32
- Blood pressure, antihypertensive treatment and stroke risk.J Hypertens. 1994; 12 (suppl 10): S5-S14
- Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.N Engl J Med. 1989; 320: 904-910
- Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomised, controlled trials.Ann Intern Med. 1993; 119: 136-145
- Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts.Lancet. 1995; 346: 1647-1653
- An overview of trials of cholesterol lowering and risk of stroke.Arch Intern Med. 1995; 155: 50-55
- Consultant views on the use of aspirin in acute cerebrovascular disease: implications for clinical trials.Postgrad Med J. 1994; 70: 185-187
- Use of antithrombotic drugs in the treatment of acute ischaemic stroke. A survey of neurologists in practice in the United States.Neurology. 1989; 39: 1631-1634
- The Stroke Data Bank: design, methods, and baseline characteristics.Stroke. 1988; 19: 547-554
- How twin cities neurologists treat ischaemic stroke. Policies and trends.Arch Neurol. 1993; 50: 1098-1103
- Between-country variations in the use of medical treatments for acute stroke.Cerebrovascular Dis. 1995; 5 ([abstr]): 272
Article info
Publication history
Accepted:
January 16,
1997
Received:
October 22,
1996
Identification
Copyright
© 1997 National Stroke Division. Published by Elsevier Inc.
